FDA Enforcement Class II Terminated

"Pressure Injectable Jugular Axillo-Subclavian Central Catheter (JACC) Product" The CG+ Arrow JACC powered by Arrow VPS Stylet permits venous access to the central circulation through a central vein. The VPS Stylet, used with the VPS Console, quickly and accurately guides the central catheters to the desired location which is the lower third of the SVC or at the cavo-atrial junction

Recall: Z-2292-2017 · Reported June 14, 2017

Enforcement

Recall Number
Z-2292-2017
Event ID
76937
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
Arrow International Inc
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
June 14, 2017
Initiation Date
March 20, 2017
Classification Date
June 6, 2017
Termination Date
December 18, 2018
Address
2400 Bernville Rd, N/A, Reading, PA, 19605-9607, United States

Description

"Pressure Injectable Jugular Axillo-Subclavian Central Catheter (JACC) Product" The CG+ Arrow JACC powered by Arrow VPS Stylet permits venous access to the central circulation through a central vein. The VPS Stylet, used with the VPS Console, quickly and accurately guides the central catheters to the desired location which is the lower third of the SVC or at the cavo-atrial junction

Reason

Arrow International initiated the recall due to reports of safety cover disengagement and needlestick injury for the BD Eclipse Needle that are packaged with certain Arrow products.

Code Info

Material number CDC-41541-JX1A

Distribution

Nationwide Distribution

Quantity

unknown-firm reports total devices distributed 43,394